全文获取类型
收费全文 | 2663篇 |
免费 | 141篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 24篇 |
儿科学 | 98篇 |
妇产科学 | 71篇 |
基础医学 | 426篇 |
口腔科学 | 90篇 |
临床医学 | 227篇 |
内科学 | 541篇 |
皮肤病学 | 46篇 |
神经病学 | 193篇 |
特种医学 | 100篇 |
外科学 | 449篇 |
综合类 | 37篇 |
预防医学 | 77篇 |
眼科学 | 38篇 |
药学 | 140篇 |
中国医学 | 5篇 |
肿瘤学 | 245篇 |
出版年
2023年 | 11篇 |
2022年 | 26篇 |
2021年 | 51篇 |
2020年 | 36篇 |
2019年 | 59篇 |
2018年 | 57篇 |
2017年 | 37篇 |
2016年 | 43篇 |
2015年 | 49篇 |
2014年 | 100篇 |
2013年 | 135篇 |
2012年 | 148篇 |
2011年 | 183篇 |
2010年 | 94篇 |
2009年 | 114篇 |
2008年 | 140篇 |
2007年 | 147篇 |
2006年 | 139篇 |
2005年 | 119篇 |
2004年 | 122篇 |
2003年 | 111篇 |
2002年 | 115篇 |
2001年 | 92篇 |
2000年 | 68篇 |
1999年 | 72篇 |
1998年 | 29篇 |
1997年 | 35篇 |
1996年 | 24篇 |
1995年 | 23篇 |
1994年 | 26篇 |
1993年 | 23篇 |
1992年 | 35篇 |
1991年 | 24篇 |
1990年 | 44篇 |
1989年 | 42篇 |
1988年 | 21篇 |
1987年 | 25篇 |
1986年 | 17篇 |
1985年 | 19篇 |
1984年 | 13篇 |
1983年 | 8篇 |
1981年 | 7篇 |
1978年 | 7篇 |
1977年 | 6篇 |
1976年 | 6篇 |
1974年 | 7篇 |
1973年 | 6篇 |
1970年 | 7篇 |
1952年 | 16篇 |
1951年 | 23篇 |
排序方式: 共有2807条查询结果,搜索用时 9 毫秒
41.
42.
Claus R?del Gerhard G Grabenbauer Thomas Papadopoulos Werner Hohenberger Hans-Joachim Schmoll Rolf Sauer 《Journal of clinical oncology》2003,21(16):3098-3104
PURPOSE: The purpose of this study was to establish the feasibility and efficacy of preoperative radiotherapy (RT) with concurrent capecitabine and oxaliplatin (XELOX-RT) in patients with rectal cancer. PATIENTS AND METHODS: Thirty-two patients with locally advanced (T3/T4) or low-lying rectal cancer received preoperative RT (total dose, 50.4 Gy). Capecitabine was administered concurrently at 825 mg/m2 bid on days 1 to 14 and 22 to 35, with oxaliplatin starting at 50 mg/m2 on days 1, 8, 22, and 29 with planned escalation steps of 10 mg/m2. End points of the phase II study included downstaging, histopathologic tumor regression, resectability of T4 disease, and sphincter preservation in patients with low-lying tumors. RESULTS: Dose-limiting grade 3 gastrointestinal toxicity was observed in two of six patients treated with 60 mg/m2 of oxaliplatin. Thus, 50 mg/m2 was the recommended dose for the phase II study. Toxicities observed at this dose level were generally mild, with only two cases of short-lived grade 3 diarrhea. Myelosuppression, mainly leukopenia, was restricted to grade 2 in 19% of patients. T-category downstaging was achieved in 17 (55%) of 31 operated patients, and 68% of patients had negative lymph nodes. Pathologic complete response was found in 19% of the resected specimens. Radical surgery with free margins could be performed in 79% of patients with T4 disease, and 36% of patients with tumors < or = 2 cm from the dentate line had sphincter-saving surgery. CONCLUSION: Preoperative XELOX-RT is a feasible and well tolerated treatment. This regimen is proposed for phase III evaluation comparing standard fluorouracil-based therapy with XELOX chemoradiotherapy. 相似文献
43.
BA Evans IA Hughes CL Bevan MN Patterson JW Gregory 《Archives of disease in childhood》1997,76(6):529-531
The androgen insensitivity syndrome is a heterogeneous disorder with a wide spectrum of phenotypic abnormalities, ranging from complete female to ambiguous forms that more closely resemble males. The primary abnormality is a defective androgen receptor protein due to a mutation of the androgen receptor gene. This prevents normal androgen action and thus leads to impaired virilisation. A point mutation of the androgen receptor gene affecting two siblings with partial androgen insensitivity syndrome is described. One had cliteromegaly and labial fusion and was raised as a girl, whereas the other sibling had micropenis and penoscrotal hypospadias and was raised as a boy. Both were shown to have the arginine 840 to cysteine mutation. The phenotypic variation in this family is thus dependent on factors other than abnormalities of the androgen receptor gene alone. 相似文献
44.
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation 总被引:6,自引:0,他引:6 下载免费PDF全文
Bejjani BP Gervais D Arnulf I Papadopoulos S Demeret S Bonnet AM Cornu P Damier P Agid Y 《Journal of neurology, neurosurgery, and psychiatry》2000,69(5):595-600
OBJECTIVE: To assess the effects of high frequency stimulation of the subthalamic nucleus (STN) on axial symptoms occurring in advanced stages of Parkinson's disease (PD). METHODS: The efficacy of STN stimulation on total motor disability score (unified Parkinson's disease rating scale (UPDRS) part III) were evaluated in 10 patients with severe Parkinson's disease. The subscores were then studied separately for limb akinesia, rigidity, and tremor, which are known to respond to levodopa, and axial signs, including speech, neck rigidity, rising from a chair, posture, gait, and postural stability, which are known to respond less well to levodopa. Patients were clinically assessed in the "off" and "on" drug condition during a levodopa challenge test performed before surgical implantation of stimulation electrodes and repeated 6 months after surgery under continuous STN stimulation. A complementary score for axial symptoms from the "activities of daily living" (ADL)-that is, speech, swallowing, turning in bed, falling, walking, and freezing-was obtained from each patient's questionnaire (UPDRS, part II). RESULTS: Improvements in total motor disability score (62%), limb signs (62%), and axial signs (72%) obtained with STN stimulation were statistically comparable with those obtained with levodopa during the preoperative challenge (68%, 69%, and 59%, respectively). When levodopa and STN stimulation were combined there was a further improvement in total motor disability (80%) compared with preoperative levodopa administration. This consisted largely of an additional improvement in axial signs (84%) mainly for posture and postural stability, no further improvement in levodopa responsive signs being found. Axial symptoms from the ADL showed similar additional improvement when levodopa and STN stimulation were combined. CONCLUSION: These findings suggest that bilateral STN stimulation improves most axial features of Parkinson's disease and that a synergistic effect can be obtained when stimulation is used in conjunction with levodopa treatment. 相似文献
45.
Dipesh E. Patel Phillippa M. Cumberland Bronwen C. Walters Joseph Abbott John Brookes Beth Edmunds Peng Tee Khaw Ian Christopher Lloyd Maria Papadopoulos Velota Sung Mario Cortina-Borja Jugnoo S. Rahi For the OPTIC Study Group 《Eye (London, England)》2022,36(6):1281
BackgroundPerimetry is important in the management of children with glaucoma, but there is limited evidence-based guidance on its use. We report an expert consensus-based study to update guidance and identify areas requiring further research.MethodsExperts were invited to participate in a modified Delphi consensus process. Panel selection was based on clinical experience of managing children with glaucoma and UK-based training to minimise diversity of view due to healthcare setting. Questionnaires were delivered electronically, and analysed to establish ‘agreement’. Divergence of opinions was investigated and resolved where possible through further iterations.Results7/9 experts invited agreed to participate. Consensus (≥5/7 (71%) in agreement) was achieved for 21/26 (80.8%) items in 2 rounds, generating recommendations to start perimetry from approximately 7 years of age (IQR: 6.75–7.25), and use qualitative methods in conjunction with automated reliability indices to assess test quality. There was a lack of agreement about defining progressive visual field (VF) loss and methods for implementing perimetry longitudinally.Panel members highlighted the importance of informing decisions based upon individual circumstances—from gauging maturity/capability when selecting tests and interpreting outcomes, to accounting for specific clinical features (e.g. poor IOP control and/or suspected progressive VF loss) when making decisions about frequency of testing.ConclusionsThere is commonality of expert views in relation to implementing perimetry and interpreting test quality in the management of children with glaucoma. However, there remains a lack of agreement about defining progressive VF loss, and utilising perimetry over an individuals’ lifetime, highlighting the need for further research.Subject terms: Paediatrics, Glaucoma 相似文献
46.
Justyna D. Kowalska Carlo Biekowski Luk Fleischhans Sergii Antoniak Agata Skrzat-Klapaczyska Magdalena Suchacz Nikolina Bogdanic Deniz Gokengin Cristiana Oprea Igor Karpov Kerstin Kase Raimonda Matulionyte Antonios Papadopoulos Nino Rukhadze Arjan Harxhi David Jilich Botond Lakatos Dalibor Sedlacek Gordana Dragovic Marta Vasylyev Antonia Verhaz Nina Yancheva Josip Begovac Andrzej Horban 《Viruses》2022,14(5)
47.
Lue Ping Zhao Jay Skyler George K. Papadopoulos Alberto Pugliese James Antonio Najera George P. Bondinas Antonis K. Moustakas Ruihan Wang Chul-Woo Pyo Wyatt C. Nelson Daniel E. Geraghty ke Lernmark 《Diabetes care》2022,45(7):1610
OBJECTIVEThe purpose was to test the hypothesis that the HLA-DQαβ heterodimer structure is related to the progression of islet autoimmunity from asymptomatic to symptomatic type 1 diabetes (T1D).RESEARCH DESIGN AND METHODSNext-generation targeted sequencing was used to genotype HLA-DQA1-B1 class II genes in 670 subjects in the Diabetes Prevention Trial–Type 1 (DPT-1). Coding sequences were translated into DQ α- and β-chain amino acid residues and used in hierarchically organized haplotype (HOH) association analysis to identify motifs associated with diabetes onset.RESULTSThe opposite diabetes risks were confirmed for HLA DQA1*03:01-B1*03:02 (hazard ratio [HR] 1.36; P = 2.01 ∗ 10−3) and DQA1*03:03-B1*03:01 (HR 0.62; P = 0.037). The HOH analysis uncovered residue −18β in the signal peptide and β57 in the β-chain to form six motifs. DQ*VA was associated with faster (HR 1.49; P = 6.36 ∗ 10−4) and DQ*AD with slower (HR 0.64; P = 0.020) progression to diabetes onset. VA/VA, representing DQA1*03:01-B1*03:02 (DQ8/8), had a greater HR of 1.98 (P = 2.80 ∗ 10−3). The DQ*VA motif was associated with both islet cell antibodies (P = 0.023) and insulin autoantibodies (IAAs) (P = 3.34 ∗ 10−3), while the DQ*AD motif was associated with a decreased IAA frequency (P = 0.015). Subjects with DQ*VA and DQ*AD experienced, respectively, increasing and decreasing trends of HbA1c levels throughout the follow-up.CONCLUSIONSHLA-DQ structural motifs appear to modulate progression from islet autoimmunity to diabetes among at-risk relatives with islet autoantibodies. Residue −18β within the signal peptide may be related to levels of protein synthesis and β57 to stability of the peptide-DQab trimolecular complex. 相似文献
48.
49.
50.